Yahoo! Finance: Biotechnology Industry News: Prima BioMed to Move Forward With Phase 2 Clinical Program for CVac(TM) in Pancreatic, Colorectal, and Triple-Negative Breast Cancers

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Prima BioMed to Move Forward With Phase 2 Clinical Program for CVac(TM) in Pancreatic, Colorectal, and Triple-Negative Breast Cancers Jun 25th 2013, 00:00 [Marketwired] - Prima BioMed Ltd today announced that it will move forward with three separate phase 2 clinical trials to evaluate the potential of CVac™ for the treatment of resectable pancreatic cancer, metastatic colorectal ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions